- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Chronic lymphocytic leukaemia (CLL) Small lymphocytic lymphoma (SLL)
- Meeting Date:
Pirtobrutinib – July 2026
- Tablet 50mg
- Tablet 100mg
Last updated
13 November 2026
